Miho Tanaka

4.4k total citations
141 papers, 3.3k citations indexed

About

Miho Tanaka is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Miho Tanaka has authored 141 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 21 papers in Surgery and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Miho Tanaka's work include Immune Cell Function and Interaction (10 papers), Neuropeptides and Animal Physiology (9 papers) and Coronary Interventions and Diagnostics (9 papers). Miho Tanaka is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Neuropeptides and Animal Physiology (9 papers) and Coronary Interventions and Diagnostics (9 papers). Miho Tanaka collaborates with scholars based in Japan, United States and United Kingdom. Miho Tanaka's co-authors include Kenji Kangawa, Tanenao Eto, Yuko Ishizaka, Kazuo Kitamura, Yoshinobu SHIMAMURA, Akira TODOROKI, Johji Kato, Mari Kawamoto, Hideki Ishii and Toyoaki Murohara and has published in prestigious journals such as Cell, Circulation and Nature Communications.

In The Last Decade

Miho Tanaka

135 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miho Tanaka Japan 33 1.2k 948 472 406 344 141 3.3k
Hiroyasu Ito Japan 40 1.1k 0.9× 438 0.5× 235 0.5× 281 0.7× 151 0.4× 238 4.9k
Ying Zhang China 37 1.6k 1.3× 305 0.3× 435 0.9× 504 1.2× 518 1.5× 276 5.4k
Chi‐Ming Lee Taiwan 39 2.1k 1.7× 1.1k 1.2× 721 1.5× 849 2.1× 185 0.5× 226 5.9k
Kathy Zimmerman United States 31 2.0k 1.6× 350 0.4× 1.6k 3.4× 471 1.2× 229 0.7× 125 4.6k
Akiko Honda Japan 33 1.7k 1.4× 467 0.5× 177 0.4× 315 0.8× 121 0.4× 141 5.1k
Weizhong Wang China 34 1.6k 1.3× 180 0.2× 408 0.9× 340 0.8× 182 0.5× 213 3.6k
C. Edwards United Kingdom 35 820 0.7× 200 0.2× 492 1.0× 331 0.8× 218 0.6× 177 4.1k
Haseeb A. Khan Saudi Arabia 36 1.2k 1.0× 185 0.2× 208 0.4× 304 0.7× 745 2.2× 291 5.2k
Xia Li China 29 1.3k 1.1× 404 0.4× 129 0.3× 133 0.3× 143 0.4× 121 3.8k
Jingxin Li China 34 1.5k 1.2× 173 0.2× 176 0.4× 242 0.6× 172 0.5× 216 4.1k

Countries citing papers authored by Miho Tanaka

Since Specialization
Citations

This map shows the geographic impact of Miho Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miho Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miho Tanaka more than expected).

Fields of papers citing papers by Miho Tanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miho Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miho Tanaka. The network helps show where Miho Tanaka may publish in the future.

Co-authorship network of co-authors of Miho Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Miho Tanaka. A scholar is included among the top collaborators of Miho Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miho Tanaka. Miho Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uejima, Tamami, Miho Tanaka, Mutsuko Kukimoto‐Niino, et al.. (2024). EVA1-antibody drug conjugate is a new therapeutic strategy for eliminating glioblastoma-initiating cells. Neuro-Oncology. 27(3). 682–694. 2 indexed citations
2.
Tanaka, Miho, Kenneth H. Hu, Bushra Samad, et al.. (2023). 1502 Tumor heterogeneity impedes immunotherapy through driving spatially organized pockets of immunosuppression. SHILAP Revista de lepidopterología. A1666–A1666. 1 indexed citations
3.
Tanaka, Miho, et al.. (2023). Effects of a smartphone app‐based diet and physical activity program for men living with HIV who have dyslipidemia: A pilot randomized controlled trial. Japan Journal of Nursing Science. 20(3). e12535–e12535. 4 indexed citations
4.
Tanaka, Miho, et al.. (2023). Predictive factors and scoring system for intravascular large B‐cell lymphoma among suspected cases: a single‐center retrospective analysis. International Journal of Dermatology. 63(1). 79–84. 1 indexed citations
5.
Kageyama, Masako, et al.. (2022). Implementation Degree Assessment Sheet for Health Program in Japan by Customizing CFIR: Development and Validation. SHILAP Revista de lepidopterología. 3(1). 20–20. 2 indexed citations
7.
Li, Meng, et al.. (2021). Factors Associated with Nursing Interventions for Smoking Cessation: A Narrative Review. SHILAP Revista de lepidopterología. 11(1). 64–74. 10 indexed citations
8.
Tanaka, Miho, et al.. (2020). Ethical Issues Around the Withdrawal of Dialysis Treatment in Japan. Asian Bioethics Review. 12(1). 51–57. 5 indexed citations
10.
Tanaka, Miho, Jason H. Fine, Oscar A. Aguilar, et al.. (2018). The Inhibitory NKR-P1B:Clr-b Recognition Axis Facilitates Detection of Oncogenic Transformation and Cancer Immunosurveillance. Cancer Research. 78(13). 3589–3603. 8 indexed citations
11.
Tanaka, Miho, et al.. (2018). Relationship between Reflective Practice Skills and Volume of Writing in a Reflective Journal. Health. 10(3). 283–288. 2 indexed citations
12.
Nakamura, Hajime, et al.. (2016). A Case of Synovial Sarcoma of the Thyroid Gland Masquerading as Anaplastic Thyroid Carcinoma. Practica Oto-Rhino-Laryngologica. 109(12). 871–876.
13.
Ishii, Hideki, Hiroshi Takahashi, Takanobu Toriyama, et al.. (2012). Impact of diabetes and glycaemic control on peripheral artery disease in Japanese patients with end-stage renal disease: long-term follow-up study from the beginning of haemodialysis. Diabetologia. 55(5). 1304–1309. 18 indexed citations
14.
Sakakibara, Takashi, Hideki Ishii, Yoshihiro Kawamura, et al.. (2011). Abstract 12514: Percutaneous Coronary Intervention is Beneficial For Better Survival Compared With Medication Alone in Chronic Hemodialysis Patients With Single-Vessel Disease. Circulation. 124. 1 indexed citations
15.
Kawamura, Yoshihiro, Hideki Ishii, Toru Aoyama, et al.. (2009). Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched analysis. Journal of Vascular Surgery. 50(5). 1057–1062. 17 indexed citations
16.
Kawai, Hideki, Miho Tanaka, Yoshihiro Murata, et al.. (2006). A case of IVUS catheter detachment after becoming entrapped with stent struts implanted two years before. 21(4). 333–337. 2 indexed citations
17.
Tanaka, Miho, et al.. (2004). P8-35 Basic evaluation of hematology analyzer XT-2000i for laboratory animals(STATISTICAL AND TEST METHODS/LOCAL STIMURATION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting). The Journal of Toxicological Sciences. 29(4). 487. 3 indexed citations
18.
TODOROKI, Akira, Miho Tanaka, Yoshinobu SHIMAMURA, & Hideo Kobayashi. (2003). Analysis of the Effect of the Configuration of the Delamination Crack on Delamination Monitoring with Electric Resistance Change Method. Journal of the Japan Society for Composite Materials. 29(3). 113–119. 5 indexed citations
19.
Kitamura, Kazuo, Yoshinari Ichiki, Miho Tanaka, et al.. (1994). Immunoreactive adrenomedullin in human plasma. FEBS Letters. 341(2-3). 288–290. 247 indexed citations
20.
Tanaka, Miho, Kazuo Kitamura, Yoshinari Ichiki, et al.. (1994). ESTABLISHMENT OF RADIOIMMUNOASSAY FOR HUMAN ADRENOMEDULLIN AND PLASMA ADRENOMEDULLIN LEVELS IN VARIOUS DISEASES. Japanese Circulation Journal-english Edition. 58(7). 494. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026